Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia · Delayed Price · Currency is MYR 1.320
+0.010 (0.76%)
At close: Jan 16, 2026
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.27 billion as of January 16, 2026. Its market cap has increased by 5.60% in one year.
Market Cap
1.27B
Enterprise Value
1.49B
Revenue
900.68M
Ranking
n/a
PE Ratio
15.20
Stock Price
1.32
Market Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.27B, an increase of 579.02%. That is a compound annual growth rate of 8.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.27B | 5.60% |
| Dec 31, 2025 | 1.20B | - |
| Dec 31, 2024 | 1.20B | -0.79% |
| Dec 29, 2023 | 1.21B | -20.94% |
| Dec 30, 2022 | 1.53B | -3.10% |
| Dec 31, 2021 | 1.58B | -33.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Malayan Banking Berhad | 133.38B |
| Public Bank Berhad | 90.19B |
| CIMB Group Holdings Berhad | 90.10B |
| Tenaga Nasional Berhad | 80.56B |
| IHH Healthcare Berhad | 74.67B |
| Press Metal Aluminium Holdings Berhad | 60.15B |
| Hong Leong Bank Berhad | 48.14B |
| Celcomdigi Berhad | 40.47B |